Annual Report by Private Issuer (Form C-AR)

Issuer Information

Name of Issuer:

iMetabolic Biopharma Corporation

Legal Status of Issuer:

Form:	Corporation
Jurisdiction of Incorporation/Organization:	NEVADA
Date of Incorporation/Organization:	11-17-2017

Physical Address of Issuer:

Address 1:	275 N Gateway Dr, Suite 104
City:	Phoenix
State/Country:	ARIZONA
Mailing Zip/Postal Code:	85034
Website of Issuer:	https://imbiopharma.com/

Annual Report Disclosure Requirements

Current Number of Employees:	4
Total Assets Most Recent Fiscal Year-end:	27787.00
Total Assets Prior Fiscal Year-end:	82459.00
Cash and Cash Equivalents Most Recent Fiscal Year-end:	25726.00
Cash and Cash Equivalents Prior Fiscal Year-end:	82459.00
Accounts Receivable Most Recent Fiscal Year-end:	2.00
Accounts Receivable Prior Fiscal Year-end:	0.00
Short-term Debt Most Recent Fiscal Year-end:	65378.00
Short-term Debt Prior Fiscal Year-end:	47853.00
Long-term Debt Most Recent Fiscal Year-end:	557779.00
Long-term Debt Prior Fiscal Year-end:	0.00
Revenue/Sales Most Recent Fiscal Year-end:	137329.00
Revenue/Sales Prior Fiscal Year-end:	129520.00
Cost of Goods Sold Most Recent Fiscal Year-end:	0.00
Cost of Goods Sold Prior Fiscal Year-end:	0.00
Taxes Paid Most Recent Fiscal Year-end:	0.00
Taxes Paid Prior Fiscal Year-end:	0.00
Net Income Most Recent Fiscal Year-end:	-99746.00
Net Income Prior Fiscal Year-end:	-120292.00

Signature

Pursuant to the requirements of Sections 4(a)(6) and 4A of the Securities Act of 1933 and Regulation Crowdfunding (§ 227.100-503), the issuer certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form C and has duly caused this Form to be signed on its behalf by the duly authorized undersigned.

Issuer:	iMetabolic Biopharma Corporation
Signature:	Urban Kiernan
Title:	CEO and Chairman

Pursuant to the requirements of Sections 4(a)(6) and 4A of the Securities Act of 1933 and Regulation Crowdfunding (§ 227.100-503), this Form C has been signed by the following persons in the capacities and on the dates indicated.

Signature:	Urban Kiernan
Title:	CEO and Chairman
Date:	05-05-2026

Pursuant to the requirements of Sections 4(a)(6) and 4A of the Securities Act of 1933 and Regulation Crowdfunding (§ 227.100-503), this Form C has been signed by the following persons in the capacities and on the dates indicated.

Signature:	Urban Kiernan
Title:	CFO
Date:	05-05-2026

Pursuant to the requirements of Sections 4(a)(6) and 4A of the Securities Act of 1933 and Regulation Crowdfunding (§ 227.100-503), this Form C has been signed by the following persons in the capacities and on the dates indicated.

Signature:	Jeffrey Zimmerman
Title:	Director and General Counsel
Date:	05-05-2026